Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan Cheng

Showing results (181-190 of 220) with videos related to

Pageof 22
Sort By:
Heart Rhythm|July 30, 2011
Complications arising from catheter ablation of atrial fibrillation: temporal trends and predictorsHana Hoyt, Aditya Bhonsale, Karuna Chilukuri, et al.
Urology Practice|February 21, 2025
Reply by AuthorsAnju Murayama, David-Dan Nguyen, Anna-Lisa V Nguyen, et al.
American Heart Journal|February 8, 2020
Modeling defibrillation benefit for survival among cardiac resynchronization therapy defibrillator recipientsKenneth C Bilchick, Yongfei Wang, Jeptha P Curtis, et al.
Heart Rhythm|October 29, 2005
Predictors of appropriate implantable defibrillator therapies in patients with arrhythmogenic right ventricular dysplasiaJonathan P Piccini, Darshan Dalal, Ariel Roguin, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|September 24, 2016
A novel transgenic mouse model of lysosomal storage disorderSonia Ortiz-Miranda, Rui Ji, Agata Jurczyk, et al.
Circulation|March 29, 2007
Infarct tissue heterogeneity by magnetic resonance imaging identifies enhanced cardiac arrhythmia susceptibility in patients with left ventricular dysfunctionAndré Schmidt, Clerio F Azevedo, Alan Cheng, et al.
Urology Practice|October 25, 2024
Industry-Sponsored Research Funding to Urologists in the United States Between 2014 and 2022Anju Murayama, David-Dan Nguyen, Anna-Lisa V Nguyen, et al.
JACC. Clinical Electrophysiology|May 16, 2018
Antibacterial Envelope Is Associated With Low Infection Rates After Implantable Cardioverter-Defibrillator and Cardiac Resynchronization Therapy Device Replacement: Results of the Citadel and Centurion StudiesCharles A Henrikson, M Rizwan Sohail, Helbert Acosta, et al.
Journal of the American College of Cardiology|May 22, 2010
Dual antiplatelet therapy and heparin "bridging" significantly increase the risk of bleeding complications after pacemaker or implantable cardioverter-defibrillator device implantationChristine Tompkins, Alan Cheng, Darshan Dalal, et al.
Journal of the American College of Cardiology|May 27, 2017
Seattle Heart Failure and Proportional Risk Models Predict Benefit From Implantable Cardioverter-DefibrillatorsKenneth C Bilchick, Yongfei Wang, Alan Cheng, et al.
Pageof 22

Showing results (181-190 of 220) with videos related to

Sort By:
Pageof 22
Heart Rhythm|July 30, 2011
Complications arising from catheter ablation of atrial fibrillation: temporal trends and predictorsHana Hoyt, Aditya Bhonsale, Karuna Chilukuri, et al.
Urology Practice|February 21, 2025
Reply by AuthorsAnju Murayama, David-Dan Nguyen, Anna-Lisa V Nguyen, et al.
American Heart Journal|February 8, 2020
Modeling defibrillation benefit for survival among cardiac resynchronization therapy defibrillator recipientsKenneth C Bilchick, Yongfei Wang, Jeptha P Curtis, et al.
Heart Rhythm|October 29, 2005
Predictors of appropriate implantable defibrillator therapies in patients with arrhythmogenic right ventricular dysplasiaJonathan P Piccini, Darshan Dalal, Ariel Roguin, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|September 24, 2016
A novel transgenic mouse model of lysosomal storage disorderSonia Ortiz-Miranda, Rui Ji, Agata Jurczyk, et al.
Circulation|March 29, 2007
Infarct tissue heterogeneity by magnetic resonance imaging identifies enhanced cardiac arrhythmia susceptibility in patients with left ventricular dysfunctionAndré Schmidt, Clerio F Azevedo, Alan Cheng, et al.
Urology Practice|October 25, 2024
Industry-Sponsored Research Funding to Urologists in the United States Between 2014 and 2022Anju Murayama, David-Dan Nguyen, Anna-Lisa V Nguyen, et al.
JACC. Clinical Electrophysiology|May 16, 2018
Antibacterial Envelope Is Associated With Low Infection Rates After Implantable Cardioverter-Defibrillator and Cardiac Resynchronization Therapy Device Replacement: Results of the Citadel and Centurion StudiesCharles A Henrikson, M Rizwan Sohail, Helbert Acosta, et al.
Journal of the American College of Cardiology|May 22, 2010
Dual antiplatelet therapy and heparin "bridging" significantly increase the risk of bleeding complications after pacemaker or implantable cardioverter-defibrillator device implantationChristine Tompkins, Alan Cheng, Darshan Dalal, et al.
Journal of the American College of Cardiology|May 27, 2017
Seattle Heart Failure and Proportional Risk Models Predict Benefit From Implantable Cardioverter-DefibrillatorsKenneth C Bilchick, Yongfei Wang, Alan Cheng, et al.
Pageof 22